Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Immunosuppressive strategies that are mediated by tumor cells.

Rabinovich GA, Gabrilovich D, Sotomayor EM.

Annu Rev Immunol. 2007;25:267-96. Review.

2.

Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.

Elluru S, Duong Van Huyen JP, Delignat S, Prost F, Bayry J, Kazatchkine MD, Kaveri SV.

Arzneimittelforschung. 2006 Jun;56(6A):461-6. Review.

PMID:
16927527
3.

Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.

Urech K, Schaller G, Jäggy C.

Arzneimittelforschung. 2006 Jun;56(6A):428-34.

PMID:
16927522
4.

Mechanisms of immune evasion by tumors.

Drake CG, Jaffee E, Pardoll DM.

Adv Immunol. 2006;90:51-81. Review.

PMID:
16730261
5.

Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.

Heinzerling L, von Baehr V, Liebenthal C, von Baehr R, Volk HD.

J Clin Immunol. 2006 Jul;26(4):347-59. Epub 2006 May 17.

PMID:
16705487
6.

Deficiences in phenotype expression and function of dentritic cells from patients with early breast cancer.

Kichler-Lakomy C, Budinsky AC, Wolfram R, Hellan M, Wiltschke C, Brodowicz T, Viernstein H, Zielinski CC.

Eur J Med Res. 2006 Jan 31;11(1):7-12.

PMID:
16504954
7.

Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma.

Duong Van Huyen JP, Delignat S, Bayry J, Kazatchkine MD, Bruneval P, Nicoletti A, Kaveri SV.

Cancer Lett. 2006 Nov 8;243(1):32-7. Epub 2006 Jan 18.

PMID:
16412563
8.

Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta1 and interleukin-6 in the development of in situ tumor immunity.

Tsai JP, Chen HW, Cheng ML, Liu HK, Lee YP, Hsieh CL, Luh KT, Wu CW, Hsu LH, Chao TY, Wang WH, Chang CM, Ting CC.

Immunobiology. 2005;210(9):661-71.

PMID:
16323703
11.

Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.

Curti A, Isidori A, Ferri E, Terragna C, Neyroz P, Cellini C, Ratta M, Baccarani M, Lemoli RM.

Leuk Lymphoma. 2004 Jul;45(7):1419-28.

PMID:
15359643
12.

T-cell response to unique and shared antigens and vaccination of cancer patients.

Parmiani G, Sensi M, Castelli C, Rivoltini L, Anichini A.

Cancer Immun. 2002 Jun 28;2:6.

13.

Stimulation of the maturation of dendritic cells in vitro by a fermented mistletoe extract.

Stein GM, Büssing A, Schietzel M.

Anticancer Res. 2002 Nov-Dec;22(6C):4215-9.

PMID:
12553059
14.

Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.

Braun JM, Ko HL, Schierholz JM, Beuth J.

Anticancer Res. 2002 Nov-Dec;22(6C):4187-90.

PMID:
12553054
15.

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.

Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S, Parmiani G.

Immunol Rev. 2002 Oct;188:97-113. Review.

PMID:
12445284
16.

Activation of dendritic cells by an aqueous mistletoe extract and mistletoe lectin-3 in vitro.

Stein GM, Büssing A, Schietzel M.

Anticancer Res. 2002 Jan-Feb;22(1A):267-74.

PMID:
12017301
17.

Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis.

Park WB, Lyu SY, Kim JH, Choi SH, Chung HK, Ahn SH, Hong SY, Yoon TJ, Choi MJ.

Cancer Biother Radiopharm. 2001 Oct;16(5):439-47.

PMID:
11776761
18.
19.

Intracellular expression of IL-4 and inhibition of IFN-gamma by extracts from European mistletoe is related to induction of apoptosis.

Stein GM, Pfüller U, Schietzel M, Büssing A.

Anticancer Res. 2000 Sep-Oct;20(5A):2987-94.

PMID:
11062712
20.

Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer.

Wolfram RM, Budinsky AC, Brodowicz T, Kubista M, Köstler WJ, Kichler-Lakomy C, Hellan M, Kahlhammer G, Wiltschke C, Zielinski CC.

Int J Cancer. 2000 Oct 15;88(2):239-44.

Supplemental Content

Support Center